Quantcast

Latest H5N1 clinical trials Stories

2012-05-31 01:33:21

Researchers at Baylor College of Medicine will receive up to $6.2 million over five years from the National Institute Of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a vaccine for severe acute respiratory syndrome, commonly called SARS. "This will be our first major effort to develop a vaccine for a potential public health emergency threat in the United States. It gets us into a new area of biodefense while in the past we've been focusing on...

2012-05-29 12:51:35

While vaccines are perhaps medicine's most important success story, there is always room for improvement. Researchers at Oregon Health & Science University's Oregon National Primate Research Center (ONPRC) appear to have done just that. As explained in a newly published research paper, Mark Slifka, Ph.D., and colleagues have discovered a new method for creating vaccines that is thought to be safer and more effective than current approaches. The research results are published online in the...

2012-04-05 09:46:20

Analysis by NIH-supported scientists may help identify requirements for HIV vaccine Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial (http://www.niaid.nih.gov/news/newsreleases/2009/pages/thaivaxstudy.aspx), those who produced relatively...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related